RobertJBuynakMD

Internal Medicine • Valparaiso, IN

Physician

Join to view full profile

Dr. Buynak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Buynak's full profile

Already have an account?

Office
454 College Ave
Valparaiso, IN 46383
Phone+1 219-462-7173

Fax+1 219-462-7504

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1995 - 1998
Harvard Medical SchoolClass of 1995

Certifications & Licensure

IL State Medical License 2005 - 2026
TX State Medical License 2023 - 2026
IN State Medical License 1998 - 2025
OH State Medical License 2023 - 2025
AL State Medical License 2023 - 2024
WI State Medical License 2023 - 2023
FL State Medical License 2012 - 2016
MN State Medical License 1996 - 1998
American Board of Internal Medicine Internal Medicine
Join now to see all

Awards, Honors, & Recognition

Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2014-2016

Clinical Trials

A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain Start of enrollment: 2014 Jul 01
Terminated
Phase 2
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Effects of the GOLO for Life System Diet With and Without GOLO Release Supplement on Glycemic Control and Insulin Resistance Start of enrollment: 2019 Oct 01
Not yet recruiting
Not Applicable

Publications & Presentations

PubMed

134 citations
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antide...
Nizar El-Khalili, Mark Joyce, Sarah Atkinson, Robert Buynak, Catherine Datto
The International Journal of Neuropsychopharmacology. 2010-08-01
181 citations
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active...
Robert Buynak, D.Y. Shapiro, Akiko Okamoto, Ilse Van Hove, Christine Rauschkolb
Expert Opinion on Pharmacotherapy. 2010-07-15
42 citations
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open...
Robert Buynak, Stephen A. Rappaport, Kevin Rod, Pierre Arsenault, Fabian Heisig
Clinical Therapeutics. 2015-11-01